Stockwinners Market Radar for July 02, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

17:48 EDT Macerich president Coppola acquires 60,000 common shares - In a regulatory filing, Macerich president Edward Coppola disclosed the purchase of 60,000 common shares of the company on June 30 at a price of $8.75 per share.

17:23 EDT Northrop Grumman awarded $337.94M Navy contract - Northrop Grumman was awarded a $337.94M cost-plus-fixed-fee, firm-fixed-price and cost reimbursable indefinite-delivery/indefinite-quantity contract. This contract provides researching alternatives, investigating and documenting new capabilities and anomalies related to H-1 avionics and weapons; and the development, integration, verification, validation, and testing of H-1 Integrated Avionics Systems, as well as identifies maintenance capabilities, upgrading and/or updating test equipment and other support equipment required to support the systems. Work is expected to be completed in June 2027. No funds will be obligated at the time of award; funds will be obligated on individual orders as they are issued. This contract was not competitively procured pursuant to Defense Federal Acquisition Regulation 6.302-1. The Naval Air Warfare Center Weapons Division is the contracting activity.

17:07 EDT Sanofi flu vaccines licensed, approved for 2022-2023 influenza season - The U.S. FDA approved Sanofi's licensure request for vaccine approval for the upcoming 2022-2023 flu season, including: Fluzone High-Dose Quadrivalent (Influenza Vaccine), Flublok Quadrivalent (Influenza Vaccine) and Fluzone Quadrivalent (Influenza Vaccine). This approval comes on the heels of the CDC's Advisory Committee on Immunization Practices preferential recommendation for adults 65+ including Fluzone High-Dose Quadrivalent and Flublok Quadrivalent. Following this licensure, Sanofi will begin to ship their vaccines helping to ensure more people, including some of our most vulnerable population of 65 years and older, will be immunized with the vaccine best suited for their needs as recommended by the ACIP.

16:43 EDT DHT Holdings repurchased 2.83M of its own shares in Q2 - DHT Holdings announced that the company has during the second quarter purchased 2,826,771 of its own shares - equivalent to 1.7% of its outstanding shares - at an average price of $5.6256. The shares have been retired upon receipt.

16:39 EDT Endo receives Nasdaq notice of non-compliance - On July 1, received notice from the Listing Qualifications Department of the Nasdaq Stock Market indicating that, because the closing bid price for the company's common stock has fallen below $1.00 per share for the last 30 consecutive business days, the company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1).

16:33 EDT Exxon Mobil sees negative impact from Russia production of $100M-$200M in Q2 - In a regulatory filing, Exxon Mobil provided a summary of factors management believes will impact 2Q 2022 results relative to 1Q 2022 results. These factors are generally limited to market dynamics, seasonal patterns, and planned activities. The company sees Q2 Russia production impact of a loss of $100M-$200M, as well as a positive impact on Q2 of $1B-$1.4B from changes in liquid prices. Exxon also sees a positive impact on Q2 of $1.5B-$1.9B from a change in gas prices.

16:13 EDT Healthcare Realty Trust announces pro-rated quarterly dividend - Healthcare Realty Trust (HR) announced that its Board of Directors has declared a cash dividend of 20.1c per share, payable on July 19 to company stockholders of record on July 14,. This pro-rated dividend represents the company's regular quarterly dividend amount pro-rated for the period beginning on the company's last dividend record date of May 16 and ending on July 14. Pro-rating the regular dividend was stipulated for both companies under the terms of the previously announced merger agreement between the company and Healthcare Trust of America (HTA). The merger is expected to close on July 20. Following the merger, HR expects that the combined company will pay a dividend for the remainder of the quarter in August and continue with the company's regular quarterly timing of dividend payments.

16:02 EDT NextMart names Oscar Maldonado CEO - NextMart announced that it has named Oscar Maldonado as the new Chief Executive Officer and president of the company effective July 1, 2022. Maldonado was the former owner and officer of Two Brothers, LLC, a specialized oil field service company, which was acquired as a wholly owned subsidiary by the company on June 16, 2022, for 30,000,000 shares of Common Stock. William Bouyea announced his resignation effective at the end of the third fiscal quarter, June 30, 2022. Maldonado has run Two Brothers Service in the Permian Basin since 2016. Before that, Maldonado worked for Occidental USA for over ten years ending with being the Production Coordinator for the State of New Mexico.

15:16 EDT Meta Platforms' Novi pilot shutting down September 1 - Meta Platform's cryptocurrency money-transfer service Novi is officially shutting down. According to the project's website, the Novi pilot will no longer be available for use after September 1.

14:22 EDT BlockFi announces agreement that gives FTX option to acquire for up to $240M - Zac Prince, CEO of BlockFi, stated in a Twitter thread: "Yesterday we signed definitive agreements, subject to shareholder approval, with FTX US for: 1. A $400M revolving credit facility which is subordinate to all client funds, and 2. An option to acquire BlockFi at a variable price of up to $240M based on performance triggers. This, together with other potential consideration, represents a total value of up to $680M. We have not drawn on this credit facility to date and have continued to operate all our products and services normally. In fact, we raised interest rates, effective today... We were presented with various unattractive options where client funds would take a haircut or be behind a lender in the capital stack. These alternatives were completely unacceptable to me, @FounderFlori and our Board and conflict with our core value of 'Clients not Customers' as well as the interests of BlockFi and our shareholders. Ultimately, we found a great partner in @FTX_US, who shares our commitment to clients. This represents the best path forward for all @BlockFi stakeholders and the crypto ecosystem as a whole. For our clients, absolutely nothing changes in terms of how you experience @BlockFi products - but there is now even more upside in the future. The FTX US platform and products are highly complementary to BlockFi and we anticipate enhancements to our services through increased collaboration. Expect more exciting news to come on this soon." Reference Link

13:44 EDT Mitsubishi Motors reports Q2 U.S. sales of 21,872 vehicles - Mitsubishi Motors North America reported second quarter 2022 sales. "Mirroring similar concerns across the auto industry, supply constraints of many vehicle lines held overall sales to 21,872, a year-over-year decrease. Nevertheless, with Mitsubishi Motors Corporation in Japan working to maximize inventory of the 2022 Outlander for U.S. customers, sales of the company's flagship vehicle bucked the general trend and were up 55.9% versus the same period 2021," the company stated.

13:32 EDT Activist SOC Investment requests SEC investigate Tesla over board plans - Activist investor SOC Investment Group requested that the Securities and Exchange Commission investigate, and decline to clear the pending proxy of Tesla based on its failure to comply with the consent decree into which Tesla and the SEC entered on September 29, 2018, to resolve the SEC's complaint alleging that the company did not have in place adequate controls over its disclosure procedures in violation of Rule 13a-15 of the Securities Exchange Act of 1934. The consent decree required Tesla to implement mandatory procedures to oversee and pre-approve written communications from then-Chair and CEO Elon Musk, including communications on Twitter, that could reasonably contain information material to the company or its shareholders. The consent decree further required that Tesla appoint two independent directors to the Board and create an independent committee to, inter alia, oversee controls and processes regarding disclosures of potentially material information. "As a result of these failures to comply with the consent decree, Tesla shareholders have experienced sharp gyrations in the value of their shares, largely stemming from exactly the type of off-the-cuff statements from Mr. Musk that prompted the SEC to take action against Mr. Musk and Tesla originally," SOC said. "Moreover, as we will illustrate below, as a result of departures by independent directors, Tesla's failure to nominate a sufficient number of new independent director candidates, and a reduction in the Board's size, Tesla's Board following the company's upcoming annual meeting will have a significantly lower proportion of independent directors than it did immediately following the company's initial and temporary compliance with the consent decree. Tesla should be required to return to compliance with the decree by nominating at least one additional independent director for election to its Board prior to its upcoming annual general meeting scheduled for August 4, 2022. Tesla's issuance of its Form PRE 14A appears to reflect a Board that fails to comply with the SEC's consent decree and the court's ongoing consent judgment in this case. The SEC should not give clearance to Tesla's preliminary proxy statement until the statement reflects company action intended to bring it back in compliance with the consent decree once again by nominating at least one additional independent director to the Board." Reference Link

13:09 EDT Honda reports June America sales down 53.6% to 71,048 cars - Honda reports June America sales down 53.6% to 71,048 vehicles amid "severe second-quarter supply issues." Reference Link

13:06 EDT Alcoa announces partial curtailment at Warrick smelter in Indiana - Alcoa announced that it will begin the process to immediately curtail one of three operating smelting lines at its Warrick Operations facility in Indiana due to operational challenges. Each of the three smelting lines at Warrick have approximately 54,000 metric tons per year of annual capacity. The one potline is expected to be fully curtailed by the end of the day on Friday, July 1. Alcoa Warrick Operations has a total nameplate capacity of 269,000 mtpy across five potlines, including the three operating potlines with 161,000 mtpy of capacity. "Our teams will be focused on ensuring that we bring down this capacity safely while protecting production at the two other operating lines," said John Slaven, Executive Vice President and COO.

13:03 EDT Baker Hughes reports U.S. rig count down 3 from last week to 750 rigs - Baker Hughes reports the U.S. rig count is down 3 from last week to 750, with oil rigs up 1 to 595, gas rigs down 4 to 153 and miscellaneous rigs unchanged at 2. The U.S. rig count is up 275 rigs from last year's count of 475 with oil rigs up 219, gas rigs up 54 and miscellaneous rigs up 2. The U.S. offshore rig count is up 1 to 17, up 3 year-over-year.

13:00 EDT Nissan reports Q2 U.S. sales down 38.6% to 183,171 units - Nissan Group announced total U.S. second-quarter sales for 2022 of 183,171 units, a decrease of 38.6% percent versus the prior year.

12:49 EDT Bed Bath & Beyond credit rating lowered to 'B-' by S&P - S&P Global Ratings lowered its issuer credit rating on Bed Bath & Beyond to "B-" from "B+" with a negative outlook. The company's "operating performance deteriorated precipitously in the first quarter and its prospects for normalizing business trends in the second half of the year have diminished," S&P said in a statement. The firm believes Bed Bath has "surrendered market share to its competitors because of poor in-stock inventory positions and merchandising decisions that have not resonated with customers." S&P expects the company's supply chain pressures, inventory management issues, and a weakening macro environment will persist and challenge its turnaround efforts.

12:19 EDT Rafael Holdings trading resumes

12:18 EDT CWA supports Microsoft's proposed Activision Blizzard takeover in FTC letter - Communications Workers of America president Christopher Shelton sent a letter to Federal Trade Commission leaderssupporting Microsoft's (MSFT) proposed $68.7B takeover of Activision Blizzard (ATVI). "We now support approval of the transaction before you because Microsoft has entered an agreement with CWA to ensure the workers of Activision Blizzard have a clear path to collective bargaining," Shelton said in the letter. "Microsoft's binding commitments will give employees a seat at the table and ensure that the acquisition of Activision Blizzard benefits the company's workers and the broader video game labor market. This labor-management compact is particularly groundbreaking and important because it reflects a shared understanding that the current labor law regime does not deliver on the rights it professes to guarantee. Workers who seek to form unions in the United States today face severe barriers to exercising basic rights of freedom of association, with frequent firings of union supporters well-documented but not discouraged through any meaningful consequences." "When quality assurance testers at Activision Blizzard subsidiary Raven studio sought to form a union and requested voluntary recognition, management refused and instead attempted to stymie workers' ability to achieve certification of their union with multiple aggressive tactics now under investigation by the NLRB," the letter continued. "The Raven QA workers persevered and now they are headed to the bargaining table where they have the ability to exchange proposals, discuss market conditions, and share first-hand experiences between workers and management. The outcome will be a better workplace that can lead the industry in high-road practices that incorporate worker voice." Reference Link

12:05 EDT Sensata sells Qinex business to Boyd for $219M - Sensata Technologies announced that it has sold its Qinex semiconductor thermal test and control business to Boyd Corporation for total consideration of $219M, including a small secondary closing. Sensata's Qinex business manufactures semiconductor burn-in test sockets and thermal control solutions. The business was formed through the combination of Sensata's semiconductor interconnect business with Wells-CTI in 2012. Prior to this divestiture, Qinex operated mostly as a stand-alone business, reporting through the Industrials business unit within Sensing Solutions. Sensata will continue to manufacture Qinex's products under a contract manufacturing agreement with Boyd for a period of 6 to 12 months.

12:00 EDT Encompass Health falls -17.7% - Encompass Health is down -17.7%, or -$9.91 to $46.14.

12:00 EDT Oak Street Health rises 11.2% - Oak Street Health is up 11.2%, or $1.84 to $18.28.

12:00 EDT Coupang rises 13.4% - Coupang is up 13.4%, or $1.71 to $14.46.

11:57 EDT Mercer announces fire at Stendal, Germany pulp mill - Mercer International has announced that a fire has occurred in the woodyard at its Stendal, Germany pulp mill. The company said, "We currently believe that there have been no injuries, and that mill personnel and local communities are not in danger. We are currently assessing the damage which appears to be isolated to the woodchip storage area and conveyor equipment. Due to the initial and ongoing containment activities we have commenced shutdown procedures and will be curtailing pulp production. More information will be forthcoming as our assessment develops."

11:47 EDT EU reaches agreement on European crypto-assets regulation - Yesterday, the European Union Council presidency and the European Parliament reached a provisional agreement on the markets in crypto-assets proposal which covers issuers of unbacked crypto-assets, and so-called "stablecoins", as well as the trading venues and the wallets where crypto-assets are held. This regulatory framework will protect investors and preserve financial stability, while allowing innovation and fostering the attractiveness of the crypto-asset sector. This will bring more clarity in the European Union, as some member states already have national legislation for crypto-assets, but so far there had been no specific regulatory framework at EU level. "Recent developments on this quickly evolving sector have confirmed the urgent need for an EU-wide regulation," said Bruno Le Maire, French Minister for the Economy, Finance and Industrial and Digital Sovereignty. "MiCA will better protect Europeans who have invested in these assets, and prevent the misuse of crypto-assets, while being innovation-friendly to maintain the EU's attractiveness. This landmark regulation will put an end to the crypto wild west and confirms the EU's role as a standard-setter for digital topics." Reference Link

11:33 EDT Toyota reports June U.S. sales down 17.9% to 170,155 vehicles - Toyota Motor North America reported U.S. sales in June of 170,155 vehicles, down 17.9% on a volume basis and down 21.1% on daily selling rate, or DSR, basis versus June 2021. June 2022 sales of electrified vehicles totaled 39,965, representing 23.5% of total monthly sales, Toyota noted. Toyota division posted June sales of 147,495 vehicles, down 18.3% on a volume basis and down 21.5% on a DSR basis. Lexus division posted June sales of 22,660 vehicles, down 15.2% on a volume basis and down 18.4% on a DSR basis. For the first half of 2022, TMNA reported U.S. sales of 1,045,697 vehicles, down 19.1% on a volume basis and down 19.6% on a DSR basis. First half electrified vehicle sales totaled 266,413, representing 25.5% of total year-to-date sales. "Despite the ongoing inventory challenges, so far this year, we launched a number of highly anticipated new products, including the Toyota battery electric bZ4X, Tundra and hybrid Tundra, and the Lexus LX, while continuing to closely focus on taking care of our customers. Later this year, customers can expect even more electrified, refreshed and limited edition Toyota and Lexus products that fit their lifestyles, all with the safety, quality and fun-to-drive features expected from us," said Jack Hollis, executive vice president, Sales, TMNA.

11:17 EDT Rafael Holdings trading halted, news pending

10:25 EDT Airbus announces 292 orders for A320 planes from Chinese airlines - Airbus (EADSY) confirmed the signature of orders with Air China, China Eastern, China Southern, and Shenzhen Airlines for a total of 292 A320 Family aircraft. Once the relevant criteria are met, these orders will enter the backlog. By the end of May, the in-service Airbus fleet with Chinese operators totaled over 2,070 aircraft, Airbus said in a statement. At the end of May the A320neo Family had totaled more than 8,000 orders from over 130 customers, it added. Airbus competes with Boeing (BA), whose shares are up 1% to $138.71 in morning trading.

10:14 EDT PHI Group, Tin Thanh Group to execute joint venture business programs - PHI Group announced that Tin Thanh Group and the Company signed a Definitive Agreement for Collaboration on June 30, 2022 to establish a new subsidiary Philux Fidelity Global Group, a Wyoming corporation, as the parent company to carry out the scope of business cooperation previously covenanted. According to the Business Cooperation Agreement signed by Tin Thanh Group and PHI Group Inc. on May 20, 2022, both companies will jointly cooperate in the following fields: Global business development for leasing of smart truck tires under the DRC-TTG brand by Tin Thanh Group by using digital technology. Development of hi-tech agro-industrial projects for closed circular energy from sorghum crops. Development of renewable energy projects from domestic and industrial wastes by using Tin Thanh Group's exclusive proprietary technology. Development of global renewable energy projects from discarded tires using Tin Thanh Group's exclusive proprietary technology. Construction of low-income housing using areas of previous waste landfills that are cleared by Tin Thanh Group's exclusive proprietary technology. Assisting Tin Thanh Group and affiliates to access capital sources and list on major international stock exchanges. Initially, Tin Thanh Group will consolidate the majority of its 40 plants that supply energy from reusable sources to industrial factories in Vietnam and other parts of the world under Philux Fidelity Global Group and take this subsidiary public on the U.S. Nasdaq Stock Market. Alongside, both companies will continue to develop and implement the other projects and programs through this subsidiary. The stock ownership in Philux Fidelity Global Group will be determined by both companies based on fairness and merits. For the first phase of the envisaged consolidation of TTG's 40 waste-to-energy plants under PFGG, TTG will hold 70% and PHIL will hold 30% of the issued and outstanding stock of PFGG immediately after the combination. As the other projects are added under PFGG, both parties will determine the updated stock ownership structure based on fairness and economic significance of each transaction.

10:07 EDT Mazda Motor reports June U.S. sales down 53.6% to 15,130 vehicles - Mazda North American Operations reported total June sales of 15,130 vehicles, a decrease of 53.6% compared to June 2021. With 26 selling days in June, compared to 25 the year prior, the company posted a decrease of 55.4% on a Daily Selling Rate, or DSR, basis.

10:00 EDT Century Therapeutics Inc trading halted, volatility trading pause

10:00 EDT Kohl's falls -19.4% - Kohl's is down -19.4%, or -$6.92 to $28.77.

10:00 EDT Direxion Daily Semiconductor Bear 3X Shares rises 8.6% - Direxion Daily Semiconductor Bear 3X Shares is up 8.6%, or $5.68 to $71.81.

10:00 EDT Revlon rises 14.9% - Revlon is up 14.9%, or 81c to $6.22.

09:56 EDT Knightscope announces ASR contract renewal for California casino - Knightscope announced that a California casino has renewed its Autonomous Security Robot contract for a third year. This client originally deployed a K3 ASR following the onset of the pandemic. Once gaming establishments were approved to reopen, the K3 supplemented guard services at a time when filling certain rolls proved to be a challenge. As operations slowly returned to normal, Knightscope and its client worked closely together to examine the use cases in which ASRs were most beneficial and subsequently identified that a K1 ASR would better suit the long-term needs of the casino.

09:52 EDT Customers Bancorp says mortgage warehouse customer filed Chapter 11 - Customers Bancorp disclosed that on June 30, one of its commercial mortgage warehouse customers filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware. Customers Bancorp currently has $25M of unsecured debt to this customer that is fully guaranteed by an affiliate of the primary shareholder of the customer that has "significant net worth and liquidity," it added. The company "expects to be repaid in full."

09:51 EDT GSK completes acquisition of Sierra Oncology - GSK plc (GSK) announced it has completed the acquisition of Sierra Oncology (SRRA), a California-based biopharmaceutical company focused on targeted therapies for the treatment of rare forms of cancer. The acquisition was approved by Sierra Oncology's shareholders on June 29. As previously announced, the acquisition of Sierra Oncology includes momelotinib, a late-stage potential new medicine with a unique dual mechanism of action that may address the critical unmet medical needs of myelofibrosis patients with anaemia. If approved, momelotinib will contribute to GSK's growing specialty medicines business, with a U.S. launch anticipated in 2023. Luke Miels, Chief Commercial Officer, GSK, said: "This acquisition expands our innovative oncology portfolio, demonstrating our commitment to improving patient outcomes and creating value for shareholders. We now have a late-stage differentiated molecule in momelotinib, which could potentially address a significant unmet need in myelofibrosis patients with anaemia. Our focus is now on execution."

09:47 EDT Borr Drilling falls -15.0% - Borr Drilling is down -15.0%, or -69c to $3.92.

09:47 EDT Encompass Health falls -20.4% - Encompass Health is down -20.4%, or -$11.45 to $44.60.

09:47 EDT Direxion Daily Semiconductor Bear 3X Shares rises 5.6% - Direxion Daily Semiconductor Bear 3X Shares is up 5.6%, or $3.72 to $69.85.

09:37 EDT Tyra Biosciences Inc trading halted, volatility trading pause

09:31 EDT Blackstone, RiseBoro enter agreement to resructure partnership - RiseBoro Community Partnership and Blackstone announced an agreement to restructure their partnership to preserve affordability at three multifamily properties totaling 190 units in Brooklyn, New York. This agreement resolves litigation between RiseBoro and the former limited partner, which Blackstone inherited in connection with a portfolio acquisition. Under the terms of the restructured agreement, RiseBoro will acquire a majority interest in the properties. In order to support RiseBoro's vital work within the Bushwick community in Brooklyn, Blackstone has committed to donate $1.2M over 15 years to fund RiseBoro's resident support services.

09:06 EDT AstraZeneca presents Imfinzi data from HIMALAYA, TOPAZ-1 trials at EASL - AstraZeneca presented data for Imfinzi combinations from the HIMALAYA and TOPAZ-1 Phase III trials at the European Association for the Study of the Liver's International Liver Congress, or EASL 2022, and the European Society for Medical Oncology's World Congress on Gastrointestinal Cancer, or ESMO World GI 2022. Exploratory sub-analyses from HIMALAYA and TOPAZ-1 were presented at ESMO World GI 2022, June 29 to July 2 in Barcelona. Additionally, health-related quality-of-life data from HIMALAYA were presented at EASL 2022, June 22 to 26 in London. An exploratory sub-analysis from the HIMALAYA Phase III trial evaluated the efficacy and safety of the STRIDE regimen or durvalumab monotherapy versus sorafenib by baseline liver function, and liver function over time in patients with unresectable liver cancer. Liver function was determined using the ALBI scoring system, a model for assessing the severity of liver dysfunction that describes worsening severity across three grades. Patients with liver cancer tend to have underlying liver cirrhosis, leading to impaired liver function and poor prognosis. Systemic therapies for advanced liver cancer have the potential to exacerbate pre-existing liver disease and increase the risk of liver-related adverse events. Data presented at ESMO World GI 2022 showed that the STRIDE regimen improved survival regardless of liver function scores at baseline, with overall survival, or OS, hazard ratios, or HR, that were generally consistent with the primary analysis in both the ALBI grade 1 subgroup and ALBI grade 2/3 subgroup. The overall response rate, duration of response and tolerability profile for STRIDE were consistent regardless of ALBI score.2 Further, liver function was stable over time for patients treated with STRIDE who remained on the trial. An additional analysis from the HIMALAYA trial was conducted using a self-reported questionnaire to assess the impact of treatment and treatment status on health-related quality-of-life in patients with unresectable liver cancer. Results presented at EASL 2022 demonstrated that patients treated with the STRIDE regimen had better quality-of-life than those treated with sorafenib, with fewer patients experiencing moderate to severe problems in domains including mobility, self-care, pain/discomfort and anxiety/depression.3 Further, treatment discontinuation was associated with a larger magnitude of worsening health status than disease progression. Following discontinuation, more patients reported experiencing moderate to extreme problems on all domains.3 These results highlight the impact of treatment discontinuation and the potential quality-of-life benefits for maintaining patients on treatment with the STRIDE regimen. Primary results from the HIMALAYA Phase III trial were published in New England Journal of Medicine Evidence in June. The trial met its primary endpoint demonstrating a statistically significant improvement of OS with a single priming dose of tremelimumab plus durvalumab every four weeks versus sorafenib.4 The safety profiles of the STRIDE regimen and for durvalumab alone were consistent with the known profiles of each medicine, and no new safety signals were identified. An exploratory subgroup analysis of patients enrolled in the TOPAZ-1 Phase III trial evaluated the efficacy and safety of durvalumab plus standard-of-care chemotherapy (gemcitabine plus cisplatin) compared to placebo plus chemotherapy by primary tumor location, including intrahepatic and extrahepatic cholangiocarcinoma and gallbladder cancer. The analysis showed a consistent OS benefit for patients treated with durvalumab and chemotherapy compared to chemotherapy alone across all primary tumor locations, with an improved OS with durvalumab: intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma and gallbladder cancer. This consistent OS benefit was observed regardless of geographic location, with patients in North America, Europe and Asia all showing benefit. The incidence of grade 3 or 4 adverse events and treatment-related adverse events were generally comparable among treatment groups, irrespective of primary tumor locations. Primary results from the TOPAZ-1 trial were presented during the ASCO GI Symposium in January and published in NEJM Evidence in June. Durvalumab in combination with standard-of-care chemotherapy demonstrated a statistically significant and clinically meaningful OS benefit versus chemotherapy alone, meeting the primary endpoint.6 Durvalumab plus chemotherapy did not increase the discontinuation rate due to adverse events compared to chemotherapy alone.

09:04 EDT Jamf introduces Jamf Safe Internet - Jamf rolled out Jamf Safe Internet to K-12 education customers across the globe. Designed to help schools protect minors from harmful content on the internet, Jamf Safe Internet allows customer admins to enforce acceptable-use policies without sacrificing the unmatched learning experience Apple devices provide.

09:03 EDT Borqs' Holu Hou Energy signed $49.8M of contracts in Q2 2022 in Hawaii - Borqs Technologies announced that its majority owned solar energy storage systems subsidiary, Holu Hou Energy, HHE, has signed with developers and property owners for nine solar plus energy storage projects in the State of Hawaii totaling $49.8M, as of the last day of Q2, 2022. Eight of the nine projects are on the island of Oahu, and one on Hawaii island. Implementation of these projects will start as early as Q3 of 2022 and be completed within 2023. Proclaims Pat Chan, Founder and CEO of Borqs: "With such solid results from our marketing efforts in Q2, we are on track to sign onto over $140 million of contracts this year surpassing our previous forecast of $128 million. This demonstrates our ESG strategy can achieve a rather aggressive growth path. We are truly thrilled that HHE's uniqueness is increasingly recognized by the renewable energy market. These recent signed contracts in Q2 testified for the customers' awareness of the HHE advantages and that we have a competitive edge over with many brands that are much more well-known than us. This is the tip of the iceberg, I believe the market will welcome our technological advances over the competition when more and more prominent clients are entrusting HHE with their energy storage needs. There is a lot more to come from Hawaii in the coming quarters and we are excited about the potentials in California as well."

09:00 EDT Blueprint Medicines granted orphan status for mastocytosis treatment - The FDA granted Blueprint Medicines orphan status for its treatment of mastocytosis, a selective KIT Inhibitor. Reference Link

08:52 EDT American Resources' reELEMENT secures working capital facility - American Resources Corporation announced that reELEMENT Technologies has put in place an independent working capital facility that will enable the division to expand to revenue and cash flow generation. This initial working capital facility of $2M will be used to expand reELEMENT's facility in terms of critical battery material production, internal lab space and additional preprocessing to scale the production of high-purity and sustainable battery and magnet grade critical and rare earth elements. reELEMENT's first Noblesville, Indiana facility has successfully completed the chromatography column preparation and system commissioning process for the first-of-its-kind rare earth element production train able to produce high-purity, magnet-grade REE oxides in the United States. Over the next few weeks, reELEMENT will commence to produce pure fractions of neodymium, praseodymium, and dysprosium and a high-purity mixed fraction of NdPr from end-of-life rare earth permanent magnets that can be used in the manufacturing of new magnets and technologies.

08:45 EDT General Motors trading halted, news pending

08:42 EDT Osisko Development appoints Laurence Farmer as general counsel - The Company is pleased to announce the appointment of Mr. Laurence Farmer as General Counsel, Vice President Strategic Development and Corporate Secretary with effect as at July 1, 2022. Mr. Farmer is joining the Company from Osisko Gold Royalties, where he held the position of Senior Counsel. With Mr. Farmer's appointment, Mr. Andre Le Bel will step down as Corporate Secretary of the Company and continue his duties with his employer Osisko Gold Royalties.

08:39 EDT Teva appoints Eric Hughes as CMO - Teva (TEVA) announced the appointment of Eric Hughes as executive VP, global R&D and CMO. Hughes will begin his employment on August 1 and will be based out of Teva's U.S. headquarters in Parsippany, NJ. Hughes has held senior positions at Vertex Pharmaceuticals (VRTX)

08:37 EDT II-VI completes acquisition of Coherent - II-VI Incorporated (IIVI) completed the acquisition of Coherent (COHR). Under the terms of the merger agreement, each share of Coherent common stock was converted into the right to receive $220.00 in cash and 0.91 of a share of II-VI common stock. The combined business will be more distributed across the value chain from materials to components, subsystems, systems, and service. II-VI's scale, at the levels of the value chain where expertise in materials matters, is complementary to Coherent's scale where laser systems play. The combined company will leverage that complementary scale in ways that will really matter to our customers in strategic markets. The combined company will serve the four markets of industrial, communications, electronics, and instrumentation, which together represent a fast-growing total addressable market of $65 billion. All four markets are growing and provide exciting opportunities for our employees to play an increasingly larger role in transforming the world. The combined company's global workforce of over 28,000 associates in 130 locations worldwide is dedicated to the Company's enduring vision of a world transformed through innovations vital to a better life today and the sustainability of future generations. II-VI will continue to be led by a proven leadership team that leverages the strengths of the combined company and will continue to leverage a Board of Directors comprised of seasoned executives and thought leaders from highly diverse industries. We are also pleased to welcome Stephen A. Skaggs and Sandeep S. Vij, former directors of Coherent, to our Board. The combined company will be organized into three business segments. Dr. Giovanni Barbarossa will continue to serve as the Chief Strategy Officer of the company and lead the Materials Segment, previously referred to as the Compound Semiconductors Segment. Sunny Sun will continue to lead the Networking Segment, which was previously the Photonic Solutions Segment. Dr. Mark Sobey, formerly the COO and Executive Vice President of Coherent, will be the President of our new Lasers Segment.

08:35 EDT Ensysce Biosciences secures $8M convertible note financing - Ensysce Biosciences announced that it has entered into a securities purchase agreement with institutional investors in the form of senior secured convertible notes and warrants exercisable for Ensysce common stock in a private placement for an aggregate investment of $8 million. The initial closing on June 30th provided $4 million on July 1st, prior to fees and offering expenses. The Notes, with total gross proceeds expected to be $8 million before fees and expenses, are convertible into shares of Ensysce common stock at a conversion price of $0.545, a 10% premium to the base price set at the time of the initial closing. The Notes have a maturity date of 18 months from the applicable closing date, were issued with an original discount of 6% and will bear interest from date of issuance at 6% per annum. Monthly principal payments in cash or common stock will begin approximately 90 days after each respective closing. The Warrants issued at the initial closing have the right to purchase up to 4,667,890 shares of common stock at an exercise price of $0.7085, a 30% premium to the conversion price, and are exercisable for five years following the date of issuance. An initial $4 million of funding was secured upon the initial closing with a second closing of $4 million under similar terms expected to occur upon satisfaction of certain conditions.

08:33 EDT Muscle Maker Grill rolls out lite 'Ranch It Up' Wraps menu - Muscle Maker Grill announced the rollout of its new lite "Ranch It Up" Wraps menu which includes four lite ranch-based wraps.

08:32 EDT VerifyMe announces SPAC liquidation, initiates new share repurchase plan - VerifyMe announced that it and its co-sponsor have elected to not extend the period for G3 VRM Acquisition Corp to consummate a business combination, and that VerifyMe has initiated a new share repurchase program. VerifyMe, together with the co-sponsor of the SPAC, has made the decision not to extend the period for the SPAC to consummate a business combination and accordingly the SPAC is expected to dissolve and liquidate in accordance with its charter. "As a result of the current market conditions, our Board of Directors determined that it was not in the best interests of the company to allocate additional financial capital at this time for the SPAC to consummate a business combination and instead will focus on our core business and recent acquisition of PeriShip. The audited financial statements of PeriShip for the years ended December 31, 2021, and 2020, which we recently filed, show income before provision for income tax of $3.1 million for the year ended 2021. On June 30, 2022, our Board of Directors also approved a new $1.5 million share repurchase program to repurchase shares of the company's common stock commencing July 1, 2022, for a period of 12 months, which we believe will provide a good return of equity and a benefit to our shareholders. This new repurchase program replaces our existing share repurchase program that was due to expire in August 2022 and is now terminated."

08:01 EDT Genetic Technologies geneType Risk Assessment Test onboarding in 16 clinics - Genetic Technologies announces the Company has commenced initial implementation of its geneType Risk Assessment Test at 16 medical practices across the East Coast of Australia. The geneType Multi Risk Test provides a comprehensive solution enabling a better understanding of a patient's risk of developing one or more of six common serious diseases before onset, accounting for more than 50% of annual mortalities and morbidities. GENE's CEO Simon Morriss noted, "Almost half of all Australians are suffering from at least one chronic health condition every year, over 212,400 people in Australia receive a diagnosis related to one of these six common serious diseases.1-3 The goal of geneType is to help clinicians make more informed decisions about the treatment of serious diseases providing actionable information to prevent, mitigate or reverse disease progression."

07:53 EDT Volvo Cars to establish EUR 1.2B electric car manufacturing plant in Slovakia - Volvo Cars announces it will establish a third manufacturing plant in Europe, positioning the company well to meet the continued demand from its customers for electric cars and capture future growth potential. The new plant will be climate neutral and build only electric cars, underpinning the company's ambition to become fully electric by 2030 and climate neutral by 2040, and to continue expanding its global production capacity to match its growth ambitions. By picking Slovakia as the location for its new plant, Volvo Cars creates a European triangle of manufacturing covering its largest sales region - complementing the Ghent plant in western Europe and the Torslanda plant in northern Europe. The new facility represents an investment of around EUR 1.2 billion. It will be located close to Kosice, in the eastern part of Slovakia, where it will benefit from a well-established automotive supply chain as it becomes the fifth car plant in the country. Volvo Cars has an ambition to move towards annual sales of 1.2 million cars by mid-decade, which it aims to meet with a global manufacturing footprint spanning Europe, the US and Asia. Construction of the Kosice plant is planned to start in 2023, with equipment and production lines installed during 2024. Series production of next-generation, pure electric Volvo cars is scheduled to start in 2026. The facility is designed to produce up to 250,000 cars per year and is expected to provide several thousand new jobs in the region. The site also allows for further expansion of the plant in future. Reference Link

07:33 EDT Kohl's trading resumes

07:32 EDT USHG Acquisition, Panera Brands decide to not extend partnership - USHG Acquisition and Panera Brands announced that, due to deteriorating capital market conditions, the parties have decided not to extend their previously announced agreement through which HUGS would have participated alongside the Panera Brands' initial public offering.

07:31 EDT Bellicum Pharmaceuticals reports inducement grants under Nasdaq listing rule - Bellicum Pharmaceuticals announced equity inducement grants to 2 new employees consisting of an aggregate of 135,000 stock options. The Compensation Committee of the Board of Directors approved the grants with an effective date of June 30, 2022. The stock options were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options have an exercise price of $1.18 per share and vest over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commencement date and 1/48 of the shares vesting monthly thereafter, subject to the new employee's continued service relationship with the Company. The stock options are subject to the terms and conditions of the Company's 2019 Equity Incentive Plan and a stock option agreement covering the grant.

07:13 EDT Redwire added to broad-market Russell 3000 Index - Redwire announced that it has been added to the broad-market Russell 3000 Index, effective since markets opened on June 27 as part of the 2022 Russell indexes annual reconstitution.

07:06 EDT Brown & Brown completes acquisition of Quinlan Insurance - Brown & Brown announced the completion of the previously announced acquisition of Quinlan Insurance by O'Leary Insurances Ltd., part of Brown & Brown.

07:04 EDT Verano Holdings announces opening of MUV Tamarac - Verano Holdings announced the opening of MUV Tamarac on Friday, July 1, the Company's 49th Florida dispensary and 102nd nationwide. MUV Tamarac, located at 6510 University Drive, is open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m., local time.

07:03 EDT OTC Markets Group welcomes PopReach to OTCQX - OTC Markets Group announced PopReach Corporation has qualified to trade on the OTCQX Best Market. PopReach Corporation upgraded to OTCQX from the Pink market.

07:02 EDT Regeneron completes acquisition of Sanofi's stake in Libtayo - Regeneron Pharmaceuticals (REGN) announced that it has completed the acquisition of Sanofi's (SNY) stake in Libtayo, providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2. Regeneron intends to update its full year 2022 financial guidance to reflect the Libtayo purchase during its second quarter earnings announcement in early August. There is no financial or accounting impact to second quarter financial results as a result of the Libtayo transaction.

07:00 EDT Knot Offshore Partners acquires KNOT Shuttle Tankers 35 AS - KNOT Offshore Partners announced that its wholly owned subsidiary, KNOT Shuttle Tankers AS, has acquired KNOT Shuttle Tankers 35 AS, the company that owns the shuttle tanker, Synnove Knutsen, from Knutsen NYK Offshore Tankers AS. The purchase price of the Acquisition, which has been financed on a non-dilutive basis using borrowings under a new and separate sale and leaseback agreement with respect to the Torill Knutsen, is $119M, less $87.7M of outstanding indebtedness. The Synnove Knutsen, a 153,000-deadweight ton DP2 Suezmax class shuttle tanker, was built by Hyundai Heavy Industries and delivered in October 2020. The vessel is operating in Brazil under a five-year time charter with Equinor Shipping Inc., providing fixed-rate firm employment through to at least the first quarter of 2027. The charterer has options to further extend the charter for up to 15 additional years. The Synnove Knutsen is the Partnership's eighteenth vessel.

06:51 EDT Eneti announces purchase of common shares by Scorpio Holdings Limited - Eneti announced that Scorpio Holdings Limited has purchased 288,697 common shares of the company at an average price of $6.26 per share in the open market. The company currently has 40,738,704 common shares outstanding, of which SHL and its affiliates own 8,924,159 or 21.9%.

06:43 EDT Macau reports June casino revenue down 62.1% to 2.48B patacas - Macau's gaming bureau reported June gross revenue from games of fortune in the region was down 62.1% year-over-year to 2.477B patacas. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO). Reference Link

06:35 EDT John Bean Technologies acquires Alco-food-machines, terms undisclosed - JBT Corporation announced it has acquired Alco-food-machines, a provider of further food processing solutions and production lines. Alco was founded in Bad Iburg, Germany in 1977. Alco expects 2022 revenue of approximately $35M with EBITDA margins in the low double digits prior to synergies. The transaction is expected to be slightly dilutive to 2022 GAAP earnings per share but approximately two cents accretive on an adjusted basis, which excludes transaction-related costs and purchase price accounting. The purchase price was undisclosed.

06:33 EDT Nektar CFO and COO Gil Labrucherie to depart, Jillian Thomsen to succeed - Nektar announced the promotion of Jillian Thomsen to senior VP and CFO. Thomsen has served as SVP, finance and chief accounting officer of Nektar since 2008, and is a key member of our executive committee. Gil Labrucherie, the company's current COO and CFO, will be departing the company to pursue another opportunity at a private biotechnology company. In April 2008, Jillian Thomsen was appointed chief accounting officer at Nektar and joined our executive committee.

06:24 EDT XPeng announces June deliveries of 15,295 Smart EVs, up 133% y/y - XPeng announced its vehicle delivery results for June and the second quarter 2022. XPeng recorded monthly deliveries in June of 15,295 Smart EVs, representing a 133% increase year-over-year, and a 51% increase over May. The company delivered 34,422 Smart EVs in total for the second quarter, ranking first among emerging auto brands in China for the fourth consecutive quarter. As of June 30, year-to-date total deliveries reached 68,983 units, representing a 124% increase year-over-year, the highest among emerging automakers in China. Beginning in mid-May, XPeng accelerated deliveries with resumed double-shift production at its Zhaoqing plant and notably, in June, the company reached the milestone of 200,000 cumulative deliveries. June deliveries consisted of 8,045 P7s, the company's smart sports sedan, 5,598 P5 smart family sedans and 1,652 G3i and G3 smart compact SUVs. In August, XPeng plans to begin accepting pre-orders for its new, flagship G9 SUV followed by an official launch in September. The company also plans to release its new City Navigation Guided Pilot after obtaining relevant approvals.

06:09 EDT North Atlantic Acquisition, TeleSign terminate business combination agreement - North Atlantic Acquisition announced that its business combination agreement with TeleSign has terminated, effective immediately. As a result, the special meeting of NAAC stockholders to approve the proposed transaction has been cancelled and NAAC will seek an alternative business combination.

05:11 EDT 3M to sell Neoplast, Neobun brands and related assets in Southeast Asia to Selic - 3M has entered into an agreement to sell its rights to the Neoplast and Neobun brands and related assets in Thailand and certain other Southeast Asia countries, including the manufacturing assets of its Ladlumkaew, Thailand, facility to Selic, a company focusing on bonding innovation serving various industries. Neoplast and Neobun products, sold primarily in Thailand and Southeast Asia, are part of the Skin Health & Wellness business in 3M's Consumer Health & Safety Division. The portfolios include sports and medical tapes, bandages and medicated products for the consumer and health care industry. As part of ongoing strategic portfolio management, 3M has decided to exit these brands and prioritize other areas within its Consumer Health & Safety Division, or CHSD. 3M previously announced that it would discontinue all manufacturing in the Ladlumkaew plant and close the facility by the end of August. This will impact approximately 250 3M Thailand employees who are eligible for severance and outplacement assistance. Selic has indicated that it intends to establish operations at the facility, including employment of interested site employees, to scale up production of Neoplast and Neobun brands and further product development for its medical device business. The sale is expected to be completed in the fourth quarter of 2022. The sale will not have a material impact on 3M's financial results.

05:03 EDT Electronic Arts launches F1 22 - Codemasters and Electronic Arts launched EA Sports F1 22, the official game of the 2022 FIA Formula One World Championship, for PlayStation 5, Xbox Series X S, PlayStation 4, Xbox One, and PC via Origin and Steam. This year's game includes new cars designed for closer racing, regulation changes with the inclusion of F1 Sprint, the introduction of the Miami International Autodrome, and circuit updates to Spain, Australia, and Abu Dhabi.